This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/507956-russia-india-sputnikv-vaccine/

The article has changed 4 times. There is an RSS feed of changes available.

Version 2 Version 3
Russia strikes deal with India to produce 100 million doses of Spuntik V Covid-19 vaccine per year Russia strikes deal with India to produce 100 million doses of Sputnik V Covid-19 vaccine per year
(about 2 months later)
The Russian Direct Investment Fund (RDIF) and Indian generic pharmaceutical company Hetero have agreed to produce more than 100 million doses of Russian-made Sputnik V Covid-19 vaccine per year on Indian soil.The Russian Direct Investment Fund (RDIF) and Indian generic pharmaceutical company Hetero have agreed to produce more than 100 million doses of Russian-made Sputnik V Covid-19 vaccine per year on Indian soil.
Production is set to start at the beginning of next year, the RDIF, which funded the development of the Russian vaccine, said in a statement.Production is set to start at the beginning of next year, the RDIF, which funded the development of the Russian vaccine, said in a statement.
RDIF chief Kirill Dmitriev said the deal will “provide the people of India with an efficient solution in this challenging period of the pandemic.” He added that Sputnik V should become “an integral part of the national vaccine portfolio” of every country.RDIF chief Kirill Dmitriev said the deal will “provide the people of India with an efficient solution in this challenging period of the pandemic.” He added that Sputnik V should become “an integral part of the national vaccine portfolio” of every country.
Director of international marketing at Hetero Labs Limited, B. Murali Krishna Reddy, hailed the collaboration as “another step towards our commitment in the battle against Covid-19.” Director of international marketing at Hetero Labs Limited, B. Murali Krishna Reddy, hailed the collaboration as “another step towards our commitment in the battle against Covid-19.” 
In August, Russia became the first country to register a vaccine for Covid-19. On Tuesday, Russian officials said Sputnik V’s efficacy rate was 91.4 percent a week after a second dose was administered to volunteers.In August, Russia became the first country to register a vaccine for Covid-19. On Tuesday, Russian officials said Sputnik V’s efficacy rate was 91.4 percent a week after a second dose was administered to volunteers.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!